• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HBED-CC的四氟苯酚盐:一种用于68Ga标记的小型重组抗体的多功能偶联剂。

Tetrafluorophenolate of HBED-CC: a versatile conjugation agent for 68Ga-labeled small recombinant antibodies.

作者信息

Eder Matthias, Wängler Björn, Knackmuss Stefan, LeGall Fabrice, Little Melvyn, Haberkorn Uwe, Mier Walter, Eisenhut Michael

机构信息

Radiopharmaceutical Chemistry, German Cancer Research Center, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.

出版信息

Eur J Nucl Med Mol Imaging. 2008 Oct;35(10):1878-86. doi: 10.1007/s00259-008-0816-z. Epub 2008 May 29.

DOI:10.1007/s00259-008-0816-z
PMID:18509635
Abstract

PURPOSE

The success of (68)Ga-labeled peptides for positron emission tomography of neuroendocrine tumors is mainly depending on the complex chemistry of this radioisotope. 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA), the chelator of choice has however limitations if its application is expanded to heat-sensitive proteins. Recombinant antibodies like single chain Fv or diabodies belong to this class of proteins. They are suited to provide imaging contrast despite the short-lived (68)Ga because of their rapid blood clearances and nanomolar affinities. The heterobifunctional agent N,N'-bis[2-hydroxy-5-(carboxyethyl)benzyl]ethylenediamine-N,N'-diacetic acid (HBED-CC) was chosen as an alternative ligand because this agent is complexing [(68)Ga]Ga(3+) much faster than DOTA at ambient temperatures.

MATERIALS AND METHODS

A versatile technology for HBED-CC conjugation of proteins and (68)Ga-labeling has been developed. This included HBED-CC-tetrafluorophenol (TFP) ester synthesis, coupling to the antibody at various pH and complexation reactions performed in 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) buffer under different conditions.

RESULTS

The synthesis of the monoreactive 2,3,5,6-tetrafluorophenolate of HBED-CC at a carboxyl group not participating in complex formation used Fe(HBED-CC) for ester formation. The removal of Fe(3+) from purified (HBED-CC)TFP ester was achieved with RP(18) cartridge technology. The conjugation chemistry was performed with mAb425 which binds to the epidermal growth factor receptor (EGFR). This protein was used for optimizing purposes only. The influence of complexation parameters like temperature, pH, reaction time, and HBED-CC/antibody ratio on the biological activity of this model antibody was investigated. Furthermore, the outcome of this labeling procedure on the biological activity of a recombinant diabody (50 kDa) was studied.

CONCLUSION

It is known that small HBED-CC/antibody ratios are prerequisites for minimal interference of labels with antigen-binding domains. Here, the coupling of about one HBED-CC per antibody proved to be sufficient for efficient (68)Ga labeling, pointing to the successful application of (68)Ga for molecular imaging with small recombinant proteins.

摘要

目的

(68)Ga标记的肽用于神经内分泌肿瘤正电子发射断层扫描的成功主要取决于这种放射性同位素的复杂化学性质。然而,如果将1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸(DOTA)(首选螯合剂)的应用扩展到热敏蛋白,则存在局限性。重组抗体如单链Fv或双抗体属于这类蛋白。由于它们的快速血液清除率和纳摩尔亲和力,尽管(68)Ga半衰期短,但它们仍适合提供成像对比度。选择异双功能试剂N,N'-双[2-羟基-5-(羧乙基)苄基]乙二胺-N,N'-二乙酸(HBED-CC)作为替代配体,因为该试剂在环境温度下比DOTA更快地络合[(68)Ga]Ga(3+)。

材料与方法

已开发出一种用于蛋白质与HBED-CC缀合及(68)Ga标记的通用技术。这包括HBED-CC-四氟苯酚(TFP)酯的合成、在不同pH下与抗体偶联以及在4-(2-羟乙基)-1-哌嗪乙磺酸(HEPES)缓冲液中在不同条件下进行的络合反应。

结果

在不参与络合形成的羧基处合成HBED-CC的单反应性2,3,5,6-四氟苯酚盐时,使用[Fe(HBED-CC)](-)进行酯形成。用RP(18)柱技术从纯化的(HBED-CC)TFP酯中去除Fe(3+)。偶联化学是用与表皮生长因子受体(EGFR)结合的单克隆抗体425进行的。该蛋白仅用于优化目的。研究了络合参数如温度、pH、反应时间和HBED-CC/抗体比例对该模型抗体生物活性的影响。此外,还研究了这种标记程序对重组双抗体(50 kDa)生物活性的影响。

结论

已知小的HBED-CC/抗体比例是标记对抗原结合域干扰最小的前提条件。在此,每个抗体偶联约一个HBED-CC被证明足以进行有效的(68)Ga标记,这表明(

相似文献

1
Tetrafluorophenolate of HBED-CC: a versatile conjugation agent for 68Ga-labeled small recombinant antibodies.HBED-CC的四氟苯酚盐:一种用于68Ga标记的小型重组抗体的多功能偶联剂。
Eur J Nucl Med Mol Imaging. 2008 Oct;35(10):1878-86. doi: 10.1007/s00259-008-0816-z. Epub 2008 May 29.
2
Ga-labeled HBED-CC Variant of uPAR Targeting Peptide AE105 Compared with Ga-NODAGA-AE105.与镓标记的NODAGA-AE105相比,uPAR靶向肽AE105的镓标记的HBED-CC变体。
Anticancer Agents Med Chem. 2018;18(9):1289-1294. doi: 10.2174/1871520618666180316152618.
3
ScVEGF-PEG-HBED-CC and scVEGF-PEG-NOTA conjugates: comparison of easy-to-label recombinant proteins for [68Ga]PET imaging of VEGF receptors in angiogenic vasculature.ScVEGF-PEG-HBED-CC 和 scVEGF-PEG-NOTA 缀合物:用于血管生成血管中 VEGF 受体的 [68Ga]PET 成像的易于标记重组蛋白的比较。
Nucl Med Biol. 2010 May;37(4):405-12. doi: 10.1016/j.nucmedbio.2010.02.001. Epub 2010 Apr 7.
4
[Ga]Ga-HBED-CC-DiAsp: A new renal function imaging agent.[镓]镓- HBED-CC- DiAsp:一种新的肾功能成像剂。
Nucl Med Biol. 2020 Mar-Apr;82-83:17-24. doi: 10.1016/j.nucmedbio.2019.12.005. Epub 2019 Dec 16.
5
Synthesis and evaluation of Ga-HBED-CC-EDBE-folate for positron-emission tomography imaging of overexpressed folate receptors on CT26 tumor cells.用于CT26肿瘤细胞上过表达叶酸受体的正电子发射断层扫描成像的Ga-HBED-CC-EDBE-叶酸的合成与评价
J Labelled Comp Radiopharm. 2018 Jan;61(1):4-10. doi: 10.1002/jlcr.3563. Epub 2017 Dec 29.
6
Synthesis, characterization and evaluation of Ga labelled monomeric and dimeric quinazoline derivatives of the HBED-CC chelator targeting the epidermal growth factor receptor.合成、表征和评价以表皮生长因子受体为靶点的 HBED-CC 螯合剂的 Ga 标记的单体和二聚体喹唑啉衍生物。
Bioorg Chem. 2020 Jul;100:103855. doi: 10.1016/j.bioorg.2020.103855. Epub 2020 Apr 26.
7
68Ga-complex lipophilicity and the targeting property of a urea-based PSMA inhibitor for PET imaging.68Ga-配合物的亲脂性和基于脲的 PSMA 抑制剂用于 PET 成像的靶向特性。
Bioconjug Chem. 2012 Apr 18;23(4):688-97. doi: 10.1021/bc200279b. Epub 2012 Mar 13.
8
Synthesis and Evaluation of Radiogallium Labeled Bone-Imaging Probes Using Oligo-γ-Carboxy Glutamic Acid Peptides as Carriers to Bone.用寡聚γ-羧基谷氨酸肽作为载体对骨骼进行放射性镓标记骨成像探针的合成与评价
Mol Pharm. 2024 May 6;21(5):2375-2382. doi: 10.1021/acs.molpharmaceut.3c01156. Epub 2024 Apr 4.
9
Optimization of Labeling PSMA with Ethanol-Postprocessed Ga and Its Quality Control Systems.乙醇后处理镓标记前列腺特异性膜抗原(PSMA)的优化及其质量控制系统
J Nucl Med. 2017 Mar;58(3):432-437. doi: 10.2967/jnumed.116.177634. Epub 2017 Jan 12.
10
Synthesis, radiolabeling, and evaluation of gastrin releasing peptide receptor antagonist Ga-HBED-CC-RM26.胃泌素释放肽受体拮抗剂Ga-HBED-CC-RM26的合成、放射性标记及评估
J Labelled Comp Radiopharm. 2019 Oct;62(12):843-849. doi: 10.1002/jlcr.3795. Epub 2019 Aug 13.

引用本文的文献

1
"One Method to Label Them All": A Single Fully Automated Protocol for GMP-Compliant Ga Radiolabeling of PSMA-11, Transposable to PSMA-I&T and PSMA-617.“一法通用”:一种符合 GMP 标准的 PSMA-11 全自动伽马放射性标记方法,可推广至 PSMA-I&T 和 PSMA-617。
Curr Radiopharm. 2024;17(3):285-301. doi: 10.2174/0118744710293461240219111852.
2
Medicinal (Radio) Chemistry: Building Radiopharmaceuticals for the Future.药用(放射性)化学:为未来构建放射性药物。
Curr Med Chem. 2024;31(34):5481-5534. doi: 10.2174/0929867331666230818092634.
3
Radiochemistry for positron emission tomography.

本文引用的文献

1
Convenient preparation of 68Ga-based PET-radiopharmaceuticals at room temperature.室温下68Ga 基正电子发射断层显像(PET)放射性药物的便捷制备
Bioconjug Chem. 2008 Feb;19(2):569-73. doi: 10.1021/bc700341x. Epub 2008 Jan 19.
2
Improved detection of cell death in vivo with annexin V radiolabeled by site-specific methods.通过位点特异性方法放射性标记膜联蛋白V改善体内细胞死亡的检测。
J Nucl Med. 2006 Sep;47(9):1546-53.
3
Molecular position of radiolabels and its impact on functional integrity of proteins.
正电子发射断层成像中的放射性化学
Nat Commun. 2023 Jun 5;14(1):3257. doi: 10.1038/s41467-023-36377-4.
4
Peptide-based positron emission tomography probes: current strategies for synthesis and radiolabelling.基于肽的正电子发射断层扫描探针:合成与放射性标记的当前策略
RSC Med Chem. 2023 Jan 6;14(4):592-623. doi: 10.1039/d2md00397j. eCollection 2023 Apr 26.
5
The diagnostic performance of F-DCFPyL PET in patients with suspected prostate cancer: A systemic review and meta-analysis.F-DCFPyL PET在疑似前列腺癌患者中的诊断性能:一项系统评价和荟萃分析。
Front Oncol. 2023 Mar 7;13:1145759. doi: 10.3389/fonc.2023.1145759. eCollection 2023.
6
Optimization of Precursor Preparation in PSMA-11 Radiolabeling to Obtain a Highly Reproducible Radiochemical Yield.优化PSMA-11放射性标记中前体的制备以获得高度可重复的放射化学产率。
Pharmaceuticals (Basel). 2022 Mar 11;15(3):343. doi: 10.3390/ph15030343.
7
Cold Kit Labeling: The Future of Ga Radiopharmaceuticals?冷试剂盒标签:镓放射性药物的未来?
Front Med (Lausanne). 2022 Feb 10;9:812050. doi: 10.3389/fmed.2022.812050. eCollection 2022.
8
AAZTA-Derived Chelators for the Design of Innovative Radiopharmaceuticals with Theranostic Applications.用于设计具有诊疗应用的创新放射性药物的基于AAZTA的螯合剂。
Pharmaceuticals (Basel). 2022 Feb 16;15(2):234. doi: 10.3390/ph15020234.
9
Synthesis and evaluation of radiogallium-labeled long-chain fatty acid derivatives as myocardial metabolic imaging agents.放射性镓标记长链脂肪酸衍生物的合成与评价及其作为心肌代谢显像剂的研究。
PLoS One. 2021 Dec 15;16(12):e0261226. doi: 10.1371/journal.pone.0261226. eCollection 2021.
10
Targeted fluorescent imaging of a novel FITC-labeled PSMA ligand in prostate cancer.新型 FITC 标记 PSMA 配体在前列腺癌中的靶向荧光成像。
Amino Acids. 2022 Jan;54(1):147-155. doi: 10.1007/s00726-021-03102-8. Epub 2021 Nov 20.
J Nucl Med. 2006 Sep;47(9):1400-2.
4
Deferoxamine as a chelator for 67Ga in the preparation of antibody conjugates.
Nucl Med Biol. 2005 Jul;32(5):513-9. doi: 10.1016/j.nucmedbio.2005.04.009.
5
Conjugation of DOTA using isolated phenolic active esters: the labeling and biodistribution of albumin as blood pool marker.
Bioconjug Chem. 2005 Jan-Feb;16(1):237-40. doi: 10.1021/bc034216c.
6
(68)Ga-labeled peptides in tumor imaging.用于肿瘤成像的(68)镓标记肽
J Nucl Med. 2005 Jan;46 Suppl 1:172S-8S.
7
Imaging the pharmacodynamics of HER2 degradation in response to Hsp90 inhibitors.对Hsp90抑制剂响应的HER2降解的药效学成像。
Nat Biotechnol. 2004 Jun;22(6):701-6. doi: 10.1038/nbt968. Epub 2004 May 9.
8
An improved method for conjugating monoclonal antibodies with N-hydroxysulfosuccinimidyl DOTA.一种将单克隆抗体与N-羟基琥珀酰亚胺基DOTA偶联的改进方法。
Bioconjug Chem. 2001 Mar-Apr;12(2):320-4. doi: 10.1021/bc0000886.
9
Bifunctional chelators for therapeutic lanthanide radiopharmaceuticals.用于治疗性镧系放射性药物的双功能螯合剂。
Bioconjug Chem. 2001 Jan-Feb;12(1):7-34. doi: 10.1021/bc000070v.
10
In vitro characterization of radiolabeled monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen.前列腺特异性膜抗原细胞外结构域特异性放射性标记单克隆抗体的体外特性研究
Cancer Res. 2000 Sep 15;60(18):5237-43.